Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
Clinical trial NCT05251909 · TERMINATED
Trial details
- NCT number
- NCT05251909
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2024-02-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.